Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials

Digital technology is transforming the development of drugs for Alzheimer's disease and was the topic of the Alzheimer's Association's Research Roundtable on its May 23–24, 2017 meeting. Research indicates that wearable devices and unobtrusive passive sensors that enable the collectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Michael, Amatniek, Joan, Carrillo, Maria C., Cedarbaum, Jesse M., Hendrix, James A., Miller, Bradley B., Robillard, Julie M., Rice, J. Jeremy, Soares, Holly, Tome, Maria B., Tarnanas, Ioannis, Vargas, Gabriel, Bain, Lisa J., Czaja, Sara J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021547/
https://www.ncbi.nlm.nih.gov/pubmed/29955666
http://dx.doi.org/10.1016/j.trci.2018.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021547/
https://www.ncbi.nlm.nih.gov/pubmed/29955666
http://dx.doi.org/10.1016/j.trci.2018.04.003

Ejemplares similares